Skip to main content

Table 1 Subject characteristics presented for the overall cohort and by CTO status

From: Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study

 

Overall cohort

(n = 1211; 100%)

CTO status

pre = no/post = no

(n = 689; 57%)

pre = yes/post = yes

(n = 275; 23%)

pre = yes/post = no

(n = 133; 11%)

pre = no/post = yes

(n = 114; 9%)

Age, years

 Mean (SD)

38 (14)

39 (14)

38 (14)

38 (12)

34 (14)

Categories, n (%)

 18–24

239 (19.7%)

134 (19.5%)

44 (16.0%)

24 (18.1%)

37 (32.5%)

 25–29

196 (16.2%)

101 (14.7%)

58 (21.1%)

18 (13.5%)

19 (16.7%)

 30–34

150 (12.4%)

95 (13.8%)

27 (9.8%)

14 (10.5%)

14 (12.3%)

 35–39

132 (10.9%)

64 (9.3%)

43 (15.6%)

15 (11.3%)

10 (8.8%)

 40–44

124 (10.2%)

64 (9.3%)

26 (9.5%)

24 (18.1%)

10 (8.8%)

 45–49

105 (8.7%)

66 (9.6%)

17 (6.2%)

15 (11.3%)

 < 10 (< 8.8%)

 50–54

101 (8.3%)

63 (9.1%)

22 (8.0%)

12 (9.0%)

 < 10 (< 8.8%)

 55–59

69 (5.7%)

43 (6.2%)

15 (5.5%)

 < 10 (< 7.5%)

 < 10 (< 8.8%)

 60–64

40 (3.3%)

25 (3.6%)

 < 15 (< 5.5%)

 < 10 (< 7.5%)

 < 10 (< 8.8%)

  ≥ 65

55 (4.5%)

34 (4.9%)

 < 15 (< 5.5%)

 < 10 (< 7.5%)

 < 10 (< 8.8%)

Sex, n (%)

 Male

779 (64.3%)

436 (63.3%)

177 (64.4%)

84 (63.2%)

82 (71.9%)

 Female

432 (35.7%)

253 (36.7%)

98 (35.6%)

49 (36.8%)

32 (28.1%)

Residence, n (%)

 Urban

1078 (89.0%)

608 (88.2%)

252 (91.6%)

118 (88.7%)

100 (87.7%)

 Rural

133 (11.0%)

81 (11.8%)

23 (8.4%)

15 (11.3%)

14 (12.3%)

CCI, mean (SD)

0.6 (1.3)

0.7 (1.4)

0.5 (1.0)

0.6 (1.3)

0.6 (1.0)

Hospitalized on index date, n (%)

161 (13.3%)

87 (12.6%)

36 (13.1%)

 < 10 (< 7.5%)

31 (27.2%)

Index SGA-LAI, n (%)

 Paliperidone

833 (68.8%)

471 (68.4%)

186 (67.6%)

95 (71.4%)

81 (71.1%)

 Aripiprazole

229 (18.8%)

126 (18.3%)

58 (21.1%)

26 (19.5%)

19 (16.7%)

 Risperidone

149 (12.3%)

92 (13.4%)

31 (11.3%)

14 (11.3%)

14 (12.3%)

  1. Abbreviations: CCI Charlson comorbidity index, CTO Community treatment order, SD Standard deviation, SGA-LAI Second generation antipsychotic long-acting injectable. Subject numbers less than 10 need to be redacted as per data privacy standards, and prevented from being back-calculated